Treats iron deficiency anemia when oral iron is ineffective or unsuitable.
🛒 How to order this item?
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
Ferinject 500 contains Ferric carboxymaltose, a medication classified under Iron replacement medicines. It is prescribed to treat iron deficiency anemia (IDA) in adults and adolescents above 14 years old who cannot tolerate oral iron supplements, require rapid iron supplementation, or have non-dialysis-dependent chronic kidney disease. Iron deficiency anemia occurs when the body lacks sufficient iron, necessary for the production of red blood cells and oxygen transportation.
Before initiating treatment with Ferinject 500, your doctor may recommend relevant tests to assess your condition. Inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding. Ferinject 500 is not suitable for children and adolescents under 14 years old, and caution should be exercised when administering it to elderly patients aged 65 years or above. Seek advice from your doctor before starting Ferinject 500.
It's uncertain if it's safe to consume alcohol with Ferinject 500. Please consult your doctor.
Ferinject 500 may be unsafe during pregnancy, as limited human studies suggest potential harm to the developing baby. Consult your doctor to weigh the benefits and risks.
Ferinject 500 is safe during breastfeeding. Studies show minimal transfer to breastmilk, posing no harm to the baby.
Ferinject 500 usually doesn't affect your ability to drive.
Likely safe in patients with kidney disease, as dose adjustment may not be necessary. Consult your doctor.
Use with caution in patients with liver disease, as dose adjustment may be needed. Consult your doctor.
Treatment of iron deficiency anemia.
Replenishes iron stores in the body, vital for forming new red blood cells and hemoglobin.
Common side effects include nausea, hypertension, flushing, decreased blood phosphorus, dizziness, vomiting, pruritus, rash, urticaria, wheezing, injection site discoloration, headache, increased alanine aminotransferase, dysgeusia, hypotension, constipation, and serious anaphylactic/anaphylactoid reactions.
Ferric Carboxymaltose is prescribed for treating iron deficiency anemia in adult patients who:
Dose: Adults: 750 mg IV once, followed by a second dose 7 days later; dosage adjustment for weight may be necessary.
Given intravenously (IV) by infusion or injection.
No formal drug interaction studies have been conducted with Ferinject.
Hypersensitivity to any component.
Store Ferric Carboxymaltose below 30°C and avoid freezing.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.